The DC activation markers CD86 and CD80, as determined by FACS analyses (Figure 1(f,g)), were significantly more increased by phage solutions from T2D donors than controls, although the latter also resulted in significant increases. The gene discussed is CD86; the disease is type 2 diabetes mellitus.